Motivated by aging research, we propose an estimator of the effect of a time-varying exposure on an outcome in longitudinal studies with dropout and truncation by death. We use an inverse-probability weighted (IPW) estimator to derive a doubly robust augmented inverse-probability weighted (AIPW) estimator. IPW estimation involves weights for the exposure mechanism, dropout, and mortality; AIPW estimation additionally involves estimating data-generating models via regression. We demonstrate that the estimators identify a causal contrast that is a function of principal strata effects under a set of assumptions. Simulations show that AIPW estimation is unbiased when weights or outcome regressions are correct, and that AIPW estimation is more efficient than IPW estimation when all models are correct. We apply the method to a study of vitamin D and gait speed among older adults.
INTRODUCTION
Longitudinal studies in aging often involve time-varying confounding, dropout, and truncation by death. Modern methods (e.g. Robins, 1998 Robins and others, 2000) handle the first two issues, but truncation by death is more vexing. Dropout and death both lead to attrition, but dropout renders outcomes unobserved whereas death renders them undefined.
We are motivated to estimate the effect of vitamin D on physical function in the Invecchiare in Chianti study ("Aging in Chianti"; shortened, "InChianti"), a longitudinal study of decline in old age comprising older Italians in which many participants dropped out or died before the study ended (Ferrucci and others, 2000) . Vitamin D is a timely topic due to the 2011 Institute of Medicine (IoM) report on vitamin D reference 156 M SHARDELL AND OTHERS intakes (Institute of Medicine, 2011) ; the Endocrine Society's guidelines (Holick and others, 2011) ; and ensuing debate (Holick and others, 2012; Rosen and others, 2012) . Both groups agree that more evidence is needed linking vitamin D to physical function, a key outcome for older adults, but they disagree on the target level for serum D] (the gold standard vitamin D measure) and rationale thereof. The IoM recommends 25(OH)D 20 ng/mL for bone health and cites insufficient evidence for improved extra-skeletal health at higher levels, but the Endocrine Society recommends 30 ng/mL for bone health and cites evidence for safety at this level. Given the need for evidence on extra-skeletal health (e.g. physical function) and lack of a formal causal inference of longitudinal studies on this topic, we aim to estimate the effect of serum 25(OH)D on physical function using guidelines from the IoM ( 20 ng/mL) and Endocrine Society ( 30 ng/mL). Since 25(OH)D in InChianti is time-varying, a method is needed to address this issue along with dropout and death.
Multiple methods have been proposed to handle truncation by death in analysis. Conditioning on being alive (Kurland and Heagerty, 2005; Shardell and Miller, 2008; Shardell and others, 2010) and unconditional analysis (Rajan and Leurgans, 2010) estimate non-causal associations, namely, mean differences in physical function by 25(OH)D among survivors, and the full cohort, respectively. In contrast, principal stratification (PS) estimates the "survivor average causal effect" (SACE), a causal contrast in a latent subgroup who would survive regardless of exposure (Egleston and others, 2007; Frangakis and Rubin, 2002; Hayden and others, 2005; Lee and others, 2010; Rubin, 2006) . PS is well motivated by mechanistic studies (Jemiai and others, 2007; Shepherd and others, 2006) , but some question if SACE is of genuine scientific interest or a stop-gap to avoid ill-defined counterfactuals of vital status (Pearl, 2011) .
Ill-defined counterfactuals are why few options exist for causal inference with truncation by death, which forms a barrier to applying formal causal inference to studies with high mortality. However, some have used inverse-probability weighting (IPW) of survivors (e.g. Glymour and others, 2010; HIV-CAUSAL Collaboration, 2012) . A concern is that IPW estimation requires counterfactuals of vital status. Tchetgen Tchetgen and others (2012a), hereafter TGSW, showed that in point exposure studies, IPW can estimate a causal contrast without counterfactuals of vital status under a set of assumptions. In this paper, we extend TGSW's exposition to longitudinal studies.
Unbiased IPW estimation requires correctly modeling dropout, mortality, and exposure weights. Thus, we propose doubly robust augmented IPW (AIPW) estimation using outcome regressions. AIPW estimation is consistent when weights or outcome regressions are correct (Bang and Robins, 2005; Robins, 2000) , and AIPW is more efficient than IPW when all models are correct.
METHODS
Consider a study of N participants with a baseline visit and J + 1 follow-up visits. Let A i ( j) be participant i's exposure at visit j, j = 0, . . . , J ; and Y i ( j) be the outcome at visit j, j = 0, . . . , J + 1. X i are baseline covariates, and and Y i (k) are undefined for k j. Finally, R i ( j) is a response indicator at visit j, where R i ( j) = 1 if data are observed, R i ( j) = 0 if data are missing, and R i (0) = 1 for all i. We address dropout, where
Suppressing subscript i, we assume data are generated in the order
Let overbars denote variable history; for example,Ā( j) = {A(0), A(1), . . . , A( j)} is exposure history through visit j. 
Target of estimation and assumptions
We focus our exposition on the first two follow-up visits of a study to reflect the design of InChianti. We aim to estimate the causal effects of A(0) on Y (1) and ofĀ(1) on Y (2). We proceed by making two core assumptions: (i) no unmeasured A − Y confounders and no unmeasured common causes of Z and Y and (ii) survivors' data are missing at random (MAR) (Rubin, 1976) . Directed acyclic graphs (DAGs) help to exemplify these assumptions; the DAG in Figure 1 encodes a pathway linking A(0) to Y (1) that satisfies MAR among survivors,
A conventional completers-only analysis is biased by conditioning on a collider {Z (1)R(1) = 1}, an effect of multiple causes or its descendant (Hernán and others, 2004) . Collider stratification bias is avoidable in Figure 1 by conditioning on L(0). TGSW and Supplementary material available at Biostatistics online show a case where no conditioning set can remove bias.
Turning to longitudinal studies, Figure 2 shows a DAG with two follow-up visits that satisfies the MAR assumption among uncensored survivors:
No conditioning set produces an unbiased completers-only estimate of the effect ofĀ(1) on Y (2) because {Y (1), L(1)} is an effect of A(0) and is a common cause of Y (2) and Z (2); that is, {Y (1), L(1)} mediates the effect of A(0) on both Y (2) and Z (2). An alternative method to overcome collider-stratification bias involves specifying the g-formula of Robins (1986) . Estimators of the g-formula, such as IPW, have well known theoretical properties (Robins, 1986 (Robins, , 1998 and include computationally accessible options. Thus, in this section we specify a g-formula that addresses truncation by death. In Section 2.2, we propose a causal model and derive the interpretation of resulting causal contrasts identified by the g-formula.
LetV (1) = {Ȳ (1),L(1)} andv(1) = {ȳ(1),l(1)}. We specify g-formulas for the first two follow-up visits: 
through both a direct pathway and an indirect pathway mediated by {Y (1), L(1)}. Under this DAG, no conditioning set is sufficient to remove selection bias in a conventional completers-only analysis.
where (1)} is the conditional distribution of L(1) at l(1); other distributions are similarly defined. By MAR, completers-only analyses to estimate expectations in (2.1) and (2.2) and to estimate the first two terms of (2.3) can be unbiased. Relations ofĀ( j) with Y ( j + 1) are contrasts g{ā( j)} − g{ā ( j)}, comparing exposure historiesā( j) andā ( j). However, these contrasts' causal interpretation depends on assumptions about mortality, due to conditioning on Z ( j + 1) = 1. In Section 2.2, we show that without additional modeling assumptions, vital status would be treated as an intervention, with
We thus propose a model to identify an alternative interpretation of g{ā( j)} − g{ā ( j)} without treating vital status as an intervention. Supplementary material available at Biostatistics online shows g{ā( j)} for general j.
Causal interpretation
To derive the causal interpretation of g{ā( j)} − g{ā ( j)}, we propose nonparametric structural equation models (Pearl, 2009) as in TGSW and extend the authors' exposition to repeated measures. These models satisfy the two core assumptions and those encoded by Figure 2 for j = 0, . . . , J :
Right-side variables of (2.4-2.7) are presumed causes of left-side variables; errors
} are independent exogenous causes. The equations explicate that L( j), A( j), and Y ( j + 1) are only defined for survivors. By MAR, (2.4-2.6) and (2.7) equal the respective functions given R( j) = 1 and R( j + 1) = 1; we therefore suppress notation for R. Like others, we define causes as interventions (Pearl, 2009) . We encode an intervention settingĀ =ā by deleting arrows intoĀ(1) in Figure 2 , replacing g A( j) with a( j) in (2.5), and replacing observables with counterfactuals in (2.4-2.7). Subscripts ofā( j) denote counterfactuals of exposure. These changes result in a set of equations of counterfactual variables:
Error terms in (2.8), (2.9) and (2.10) are unchanged from (2.4), (2.6), and (2.7), respectively, because errors are presumed to be exogenous. The individual causal effect ofā
, which is only defined in the principal stratum {Zā ( j) ( j + 1) = Zā ( j) ( j + 1) = 1} and equals
is an expectation of (2.11). Deriving average PS effects ofĀ( j) on Y ( j + 1) requires counterfactuals ofĀ( j) and components of {L( j),Ȳ ( j)} that mediate the effect ofĀ( j) on both Y ( j + 1) and Z ( j + 1). First consider the effect of Figure 1 , where no variable mediates the effect of A(0) on both Y (1) and Z (1). Replacing observables with counterfactuals in (2.5-2.7) setting
(2.12)
An implication of (2.12) is that the PS direct effect, given L(0), is
(2.13) 160
M SHARDELL AND OTHERS
Since (2.4-2.7) imply (2.12), the g-formula (2.1) under (2.4-2.7) identifies the causal contrast
(2.14)
The effect (2.14) is a weighted average of (2.13) and is interpreted as the L(0)-standardized PS effect. Assumption (2.12) is crucial to identify a causal contrast that does not rely on counterfactuals of Z . Assumption (2.12) implies that the quantity (0)}, which can be estimated by observed data, can identify a mean within a principal stratum: 
That is, the "cross-world" independence assumption at follow-up visit 2 is a function of counterfactual variables of mediators of the effect of A(0) on both Y (2) and Z (2). From (2.15), the PS controlled direct effect, given
(2.16) Equation (2.16) is a controlled direct effect because {Y (1), L(1)} is set to the same value, {y(1), l(1)}, for both counterfactual outcomes. Therefore, under (2.4-2.7), and hence (2.15),
where F Y (2) ( ) is the distribution of Y (2) evaluated at . That is, (2.4-2.7) implies (2.15), which implies that the mean of observable Y (2) conditioned on Z (2) = 1 and past observables, which can be estimated by the data, equals the mean of a counterfactual variable within a principal stratum. Equations (2.4-2.7) encode additional independence assumptions that ensure that the g-formula identifies a function of PS controlled direct effects at follow-up visit 2. Namely, for j = 1, setting
Independence assumption (2.18) implies that the distribution of L(1) conditioned on Z (1) = 1 and past observables can be interpreted as a distribution within principal strata. Define 19) where the use of counterfactuals follows from (2.4-2.7) and implied assumptions (2.12), (2.15), and (2.18).
Replacing the expectation in g-formula (2.2) with a counterfactual one from (2.17), and replacing (2.3) with (2.19) then plugging into (2.2) yields the identified causal contrast,
a difference in integrals of mean counterfactuals within principal strata. Integrals are taken over differing counterfactual distributions; FV a(0) (1) {v(1)} = FV a (0) (1) {v(1)}, in general, for a(0) = a (0). To derive the causal interpretation, we add (and subtract) strategic terms to obtain 20) where {y (1), l (1)} is a fixed reference value of {Y (1), L(1)}. Rearranging the first three terms in (2.20), noting that the last term equals 0, and applying (2.17) leads to (1) toā (1) 
Estimation
As described in Robins (1998) , the g-formulas (2.1) and (2.2) can be estimated using IPW estimation. Herein, we describe an IPW estimator for g{ā( j)} and use it to derive a doubly robust AIPW estimator. To do so, we assume positivity for mortality, exposure, and dropout, i.e. any possible mortality time, pre-death exposure history, and pre-death dropout time can occur (Robins and Rotnitzky, 1992) . To perform IPW estimation, one specifies the functional form of the g-formula, rather than the conditional distributions; that is, the left-hand sides of (2.1) and (2.2), rather than the right-hand sides. In AIPW estimation, the functional forms of the right-hand sides of (2.1) and (2.2) are additionally specified. To be concrete, we consider a specific g{ā( j)}:
where cum{ā( j)} = j k=0 a(k), the cumulative exposure, and g{ā( j),
2.3.1 IPW estimator. Inverse probability of exposure weighted estimation can consistently estimate (2.22) in longitudinal studies because it can handle collider-stratification like that shown in Figure 2 (Bryan and others, 2004; Robins and others, 2000) . To estimate (2.22) with death and dropout, weights are also used to ensure that Z and R are statistically independent of their common causes of Y .
To specify the weights, let
where f {· | ·} is a conditional probability mass or density function. Similarly, let p Z (k+1) 
The SW are called stabilized weights due to the numerator terms that improve efficiency (Robins, 1998) . The IPW estimator for β solves the estimating equation,
where
An independence correlation avoids bias from any dependence of R( j + 1) or Z ( j + 1) onȲ ( j) (Tchetgen Tchetgen and others, 2012b) . SW is unknown, thus an estimator,Ŝ W , is plugged into (2.23).β i pw solves (2.23) and is consistent due to m-estimation and positivity for exposure, mortality, and dropout with correct SW . and inconsistent if SW is incorrect. AIPW estimation can address both problems. The AIPW estimator is calculated by projecting U IPW onto the nuisance tangent space, which here is the Hilbert space spanned by mean-0 functions of A( j), Z ( j + 1), and R( j + 1), conditioned on the past equipped with the covariance operator. The estimating equation, U AIPW , is U IPW minus its projection and is located in the orthogonal complement of the nuisance tangent space. A technical treatment of Hilbert spaces and projections for missing data or causal inference is in van der Laan and Robins (2003) and Tsiatis (2006) . In the Supplementary Material available at Biostatistics online, we derive the AIPW estimator and its variance, and we provide a proof of double robustness.
SIMULATION STUDY
We simulated 5000 datasets with N = 1000 and two follow-up visits. L(0) = {X, Y (0)} were N (0, 1), and binary A(0) was assigned using
The true data-generating models in Table 1 of Supplementary material available at Biostatistics online result in
, and g{ā(1) = (1, 1)} = 2. Thus, g{ā( j), β} in (2.22) has β = {0, −2, 2}; that is, the average causal effect, β 2 , is 2. Table 1 shows estimates under both true and false models in Table 1 of Supplementary material available at Biostatistics online. IPW estimates were biased when false models were used to estimate SW , whereas AIPW estimates were biased only when both SW and outcome meansm = {m Y (1) , m Y (2) } were incorrect. When SW was correctly modeled, AIPW with correctm was more efficient than IPW.
DATA ANALYSIS: THE INCHIANTI STUDY
We aim to assess the effect of 25(OH)D on gait speed, a measure of physical function, in InChianti. Low 25(OH)D relates to frailty (Shardell and others, 2012) , of which slow gait speed is a part. Data here include 905 older adults. Follow-up visits were planned at 3 and 6 years post baseline; by year 6, 163 adults died, 288 dropped out, and 454 had complete data.
Sufficient serum 25(OH)D, according to the IoM ( 20 ng/mL) or Endocrine Society ( 30 ng/mL), is not an intervention per se, but it indicates self-selected vitamin D exposure. Thus, participants "intervene" We estimated (2.22) using IPW and AIPW. We also estimated associations using generalized estimating equations (GEE) (Liang and Zeger, 1986) , weighted independence estimating equations (W-IEE) partly conditioned on being alive with weights for dropout only (Kurland and Heagerty, 2005; Shardell and Miller, 2008; Shardell and others, 2010) , and multiply-weighted GEE (MW-GEE) with weights for deaths and dropout (Rajan and Leurgans, 2010) . We conditioned on covariates in GEE, W-IEE, and MW-GEE; logistic regression estimated all weights. Table 2 showsβ 2 from (2.22) and covariate-adjusted analogs. When assessing 25(OH)D 20 ng/mL, we found that the AIPW estimate was the smallest (0.021 m/s), and the IPW estimate was the largest (0.056 m/s); both of which are interpreted at the first follow-up visit as PS direct effects of 25(OH)D on gait speed averaged over age, sex, and baseline lifestyle factors and comorbidities; and at the second follow-up as PS-controlled direct effects averaged over age, sex, and lifestyle factors and comorbidities measured at baseline and the first follow-up visit plus the difference of PS direct effects of lifestyle factors and comorbidities on gait speed averaged over the distributions of lifestyle factors, comorbidities, and previous gait speed at high versus low 25(OH)D. Other estimates are covariate-adjusted non-causal associations of 25(OH)D with gait speed conditioned on being alive and observed (GEE), conditioned on being alive (W-IEE), and for an immortal cohort (MW-GEE). When 25(OH)D 30 ng/mL was assessed, we found again that the AIPW estimate was the smallest (0.0003 m/s), and the IPW estimate was the largest (0.055 m/s). Overall conclusions from this analysis about the causal effect of 25(OH)D on gait speed are consistent across IoM and Endocrine Society guidelines. Not only is the IPW point estimate larger than the AIPW point estimate, the 95% confidence intervals for β 2 (β 2 ± 1.96 SE) estimated using IPW exclude 0, whereas the 95% confidence intervals estimated using AIPW include 0. Thus, we found some evidence that sufficient 25(OH)D causes faster gait speed, regardless of 25(OH)D guideline, but the results are not robust to model misspecification. A caveat is that a causal interpretation depends on assumptions from Sections 2.1 and 2.2.
Causal inference with dichotomized continuous exposures is controversial, because counterfactuals of such exposures are vague to the extent that a hypothetical intervention is unspecified (Hernán, 2005; Robins and Greenland, 2000) . Van der Laan and others (2005) and Hernán and VanderWeele (2011) showed that the average effect of dichotomized exposures, such as 25(OH)D, is the effect averaged over the population distribution of continuous 25(OH)D, which may not be transportable across populations.
DISCUSSION
We described IPW and doubly robust AIPW estimators of causal effects in longitudinal studies with truncation by death. Extending the exposition by TGSW, we showed that the identified causal contrast is a function of weighted averages of PS effects. The IPW approach can be performed using off-the-shelf software, which removes a barrier to applying causal inference to aging research; however, the causal contrast has the same limitations as SACE due to its dependence on indirect PS effects. In the context herein, the causal contrast at the second follow-up visit is challenging to interpret, a PS-controlled direct effect plus the difference of integrated indirect PS effects, due to factors that mediate the effect of exposure on both outcome and mortality. TGSW also considered these mediators for a single follow-up visit. In Supplementary material available at Biostatistics online, we include these mediators for all follow-up visits of a longitudinal study.
A causal contrast that handles truncation by death ideally satisfies the criteria being easily interpreted, easily estimated, philosophically sound, and scientifically interesting. A practical challenge is that no proposed contrast satisfies all four criteria. Counterfactuals of exposure A and vital status Z , Yāz, can lead to contrasts that are easily interpreted as controlled direct effect of A on Y setting Z = 1, otherwise known as the "death blocking" causal effect (Joffe, 2011) , and can be estimated using IPW; however, such counterfactuals are ill-defined unless intervention A can prevent/delay death. SACE avoids specifying counterfactuals of vital status via either monotonicity or "cross-world" independence assumptions (Hayden and others, 2005; Egleston and others, 2007) and is interpretable, but it is more challenging to estimate in longitudinal studies of time-varying exposures without additional assumptions (Tchetgen Tchetgen, 2013) . The causal contrast proposed herein avoids counterfactuals of vital status via "cross-world" independence assumptions and is easily estimable, but at the cost of interpretability. Lastly, scientific interest of both the "death blocking" contrast and SACE (and by extension, the contrast proposed herein) has been questioned (Pearl, 2011; Joffe, 2011) ; thus an objective for the biostatistics community on truncation by death is to define a causal contrast that satisfies this elusive criterion. Until then, causal contrasts that can be estimated using off-the-shelf statistical software can help raise awareness of truncation by death among practitioners and are an improvement over the usual practices of ignoring selective survival or treating mortality as synonymous with missingness.
Regarding doubly robustness estimation, recently proposed methods have shown improved efficiency over AIPW when outcome regression models are incorrect (Rotnitzky and others, 2012; Tan, 2010; Tsiatis and others, 2011; van der Laan, 2010 , and references therein). Adapting these methods to handle truncation by death is a priority for future research.
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